Company Long-Term Loans and Borrowings: AbCellera (ABCL)

Public company logo of AbCellera Biologics (ABCL)

ABCL's price history shows long-term debt at 0.14. The high profitability of AI services is temporarily reduced by research and development costs, while profit growth is tied to patent royalties. Capitalization is based on fees collected from pharmaceutical companies for the use of microfluidic algorithms. Revenue is generated through entry fees, bonuses for successful testing, and future percentages from drug sales.

ABCL AbCellera Biologics Inc Company Long-Term Debts (07/04/2022 - 10/30/2026)

abcellera.com (ABCL) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price AbCellera Bio|ABCL - Price Target Chart
- company stock exchange capitalization indicators:
Market Value AbCellera|ABCL - Total Company Value
- book capitalization information:
Accounting Value per Share AbCellera|ABCL - Book Capitalization|Market Capitalization to Book Value Ratio abcellera.com|ABCL - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio AbCellera Biologics|ABCL - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient AbCellera|ABCL - Company Debts|Debt to Book Value AbCellera|ABCL - Company Long-Term Debt|Company Current Liabilities AbCellera|Quick Ratio abcellera.com
- earnings and multiples data:
ABCL - Company Net Income
Analysis of all company metrics:ABCL - AbCellera Biologics Inc
Brand item of AbCellera

Investors must balance the growth potential of AbCellera Biologics (ABCL) with debt sustainability to avoid the risk of excessive financial leverage. An analysis of the company's long-term debt on the GURU.Markets platform displays obligations with maturities exceeding one year, allowing for an assessment of AbCellera Biologics' investment activity in developing its antibody discovery IT platform and its risk diversification through partnerships with pharma behemoths.

Competitors of AbCellera Biologics (ABCL)

Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities TRML|Company Long-Term Debts Precigen Corp|Company Long-Term Debt Pharming Group N.V. (PHAR)|nektar.com - Company Long-Term Indebtedness|Company Long-Term Debts UPB (Upstream Bio)|Zenas Bio (ZBIO) - Long-Term Debt|Immunome Corp - Company Long-Term Debts|GOSS - Company Long-Term Debts|KALV: Company Long-Term Debts|SEPN (septerna.com) - Company Long-Term Debt|PVLA (Pieris Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Savara Inc (SVRA)|Company Long-Term Debts RIGL|ANAB - Long-Term Debt|Company Long-Term Debt Astria Therapeutics ATXS|engene.com - Company Long-Term Debt|RAPT - Company Long-Term Debt|JBIO: Company Long-Term Debt|ACRS: Company Long-Term Debts|Long-Term Debt Kyverna Therapeutics, Inc (KYTX)|Company Long-Term Debt Tiziana Life Sciences|CABA: Company Long-Term Loans and Borrowings|Company Long-Term Debts VTYX|Company Long-Term Debts Theratechnologies, Inc. (THTX)|Avalo Therapeutics Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ELDN|Agenus - Company Long-Term Debts|CLYM: Company Long-Term Debt|ZURA: Company Long-Term Debts|ATYR - Long-Term Debt Volume|Company Long-Term Debt Adagene Inc|Long-Term Debt Ikena Oncology, Inc. IMA|Company Long-Term Debt Shattuck Labs, Inc. (STTK)|Company Long-Term Debt EQ (equilliumbio.com)|Company Long-Term Debt Connect Biopharma Holdings Limited CNTB|Immunic Therapeutics (IMUX) - Long-Term Debt|Atara Biotherapeutics Inc - Company Long-Term Debts|Long-Term Indebtedness InflaRx N.V. (IFRX)|XFOR: Company Long-Term Debts|ACET - Long-Term Debt Volume|CELU (Celularity Inc) - Company Long-Term Debts|Company Long-Term Liabilities INmune Bio Inc (INMB)|Company Long-Term Debt Barinthus Bio (BRNS)|Long-Term Debt Volume Kezar Life Sciences Inc|Company Long-Term Debts SABS (SAB Biotherapeutics)|Company Long-Term Debts akaritx.com AKTX|Enlivex Therapeutics, Ltd. - Company Long-Term Debts|QTTB: Company Long-Term Debt|GOVX: Company Long-Term Debts|Company Long-Term Liabilities Edesa Biotech Corp|Company Long-Term Debt iBio, Inc.|Company Long-Term Debt CARM|Company Long-Term Debt XTL Biopharmaceuticals Ltd. (XTLB)|BOLT: Long-Term Liabilities|Company Long-Term Debts HCWB (HCW Biologics)|Company Long-Term Loans and Borrowings APVO|AIM ImmunoTech - Company Long-Term Debts|ADTX - Company Long-Term Debts|GRI Bio (GRI) - Company Long-Term Debt|XORTX Therapeutics Inc - Company Long-Term Loans and Borrowings|Company Long-Term Debt ReShape Lifesciences|Company Long-Term Liabilities Revelation Biosciences Corp (REVB)|Company Long-Term Debts INDP|Company Long-Term Debts scinai.com (SCNI)|CalciMedica - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings AFMD|Allakos Therapeutics - Company Long-Term Debts|Long-Term Debt Volume HOOKIPA Pharma Inc. HOOK|igmbio.com (IGMS) - Company Long-Term Debt|Company Long-Term Liabilities iteostherapeutics.com|Company Long-Term Debt Ocean Biomedical|Company Long-Term Liabilities TC BioPharm (Holdings) Plc (TCBP)|Company Long-Term Liabilities THRD (Third Harmonic Bio, Inc)